Most venture capitalists think that Tech investing has been what makes the best returns – which is why they’re pouring money into Facebook, LinkedIn, Twitter, and the like. They may be right today and in the future, but at least over the past decade, they’ve been wrong: in the 2000′s, venture investing in the Life Sciences has outperformed venture investing in Tech.
The venture business is now 12 years into a slump in returns that has discouraged even the most enthusiastic investors and limited partners in the space. Yet over the past 18 months, hope has sprung eternal amongst IT and Internet venture investors driven largely by a daily barrage of blog and news headlines covering the exponential growth and dramatic returns prospects of a small handful of social networking and gaming companies.
To read the full, original article click on this link: Life Sciences: The Rodney Dangerfield of Venture Capital - Bruce Booth - Life Sci VC - Forbes
Author: Bruce Booth
